Nexalin Technology (NXL) Other Operating Expenses (2021 - 2026)
Nexalin Technology's (NXL) quarterly Other Operating Expenses came in at $993856.0 in Q1 2026, up 41.34% year-on-year from $703174.0 in Q1 2025, and down 23.33% quarter-over-quarter from $1.3 million in Q4 2025.
Nexalin Technology (NXL) Other Operating Expenses (2021 - 2026) Analysis & Trends
Nexalin Technology's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $993856.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 41.34% year-over-year to $993856.0 in Q1 2026; TTM through Mar 2026 was $4.4 million, a 68.18% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 78.97% from the prior year.
- Other Operating Expenses declined to $993856.0 in Q1 2026 per NXL's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.5 million in Q4 2023 and bottomed at $171774.0 in Q3 2022.
- The 5-year median for Other Operating Expenses is $554246.0 (2024), against an average of $750185.8.
- Across the five-year window, Other Operating Expenses soared 631.95% in 2023 and slumped 67.85% in 2024, its largest moves.
- Year by year, Other Operating Expenses stood at $343244.0 in 2022, then surged by 631.95% to $2.5 million in 2023, then slumped by 67.85% to $807733.0 in 2024, then soared by 60.48% to $1.3 million in 2025, then retreated by 23.33% to $993856.0 in 2026.
- Per Business Quant, the three latest NXL Other Operating Expenses figures stand at $993856.0 (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nexalin Technology | 9.32 Mn | 6.61 Mn | 13,133.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 993,856.00 |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 755,822.00 |
| Mar 31, 2025 | 703,174.00 |
| Dec 31, 2024 | 807,733.00 |
| Sep 30, 2024 | 556,478.00 |
| Jun 30, 2024 | 548,447.00 |
| Mar 31, 2024 | 554,246.00 |
| Dec 31, 2023 | 2.51 Mn |
| Sep 30, 2023 | 490,532.00 |
| Jun 30, 2023 | 423,481.00 |
| Mar 31, 2023 | 457,923.00 |
| Dec 31, 2022 | 343,244.00 |
| Sep 30, 2022 | 171,774.00 |
| Jun 30, 2022 | 350,369.00 |
| Mar 31, 2022 | 434,050.00 |
| Dec 31, 2021 | 306,401.00 |
| Sep 30, 2021 | 220,513.00 |